Virginian-Pilot: DEA Has Bad Relationship with Facts, Science on Drug Risks

Photo by Steve Neavling.

Photo ~ means of Steve Neavling.

By Editorial Board
Virginian-Pilot

Leaders of America’s Drug Enforcement Administration obtain long demonstrated a shockingly casual kindred with facts and science on remedy risks.

The idea that marijuana — completely lawful in several states and available since medical use in most — should have ~ing listed on the same Schedule 1 with heroin, bath salts and Ecstasy is the beneficent of laughable conclusion only a zealot could justify.

The DEA is supposed to have existence a dispassionate law enforcement agency, doing its most profitably to keep America safe. But whereas it wastes time, energy and money on the indefensible, it undermines the agency’s exceedingly legitimacy.

Take cannabidiol, commonly called CBD.

Earlier this month, the DEA classified CBD, longitudinally with other marijuana derivatives, as Schedule 1 drugs, that means they have “no popularly accepted medical use and a dignified potential for abuse.”

Except that’s plainly not true. CBD — which doesn’t give the high of THC — has well-established medical uses.

According to a 2013 study published in the British Journal of Clinical Pharmacology, “CBD acts in more experimental models as an anti-incendiary, anticonvulsant, anti-oxidant, anti-emetic, anxiolytic and antipsychotic actor, and is therefore a potential remedy for the treatment of neuroinflammation, epilepsy, oxidative injury, vomiting and nausea, uneasiness and schizophrenia, respectively.”

It’s triggered ~ dint of. some journals’ routine practice of charging authors by means of-page fees.

Recent Comments

    Archives